findmyKOL

Roy Colven, MD

Basic profile

University of Washington

ORCIDNone on fileNPI
RegionSeattle, WA · WestSpecialtyDermatologyFocusDermatology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Roy Colven is a Dermatology physician affiliated with University of Washington. OpenAlex indexes 32 publications with 752 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
32publications

Distinct works indexed by OpenAlex.

752citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    27.1%
    Corticosteroid17.6%
    Triamcinolone Acetonide100%
    Part D39 patients
    Vitamin D Analog3.4%
    Calcipotriene100%
    Part D<11 patients

    + 2 more classes in this area

  • Sensory organs

    25.2%
    Corticosteroid25.2%
    Clobetasol Propionate41%Betamethasone Diprop Augmented37%Hydrocortisone22%
    Part D20 patients
  • Cancer & immunology

    22.7%
    TNF inhibitor8.2%
    Humira(Cf) Pen63%Enbrel Sureclick37%
    Part D<11 patients
    Calcineurin inhibitor6.9%
    Tacrolimus100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”